FI20055496A0 - Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit - Google Patents

Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit

Info

Publication number
FI20055496A0
FI20055496A0 FI20055496A FI20055496A FI20055496A0 FI 20055496 A0 FI20055496 A0 FI 20055496A0 FI 20055496 A FI20055496 A FI 20055496A FI 20055496 A FI20055496 A FI 20055496A FI 20055496 A0 FI20055496 A0 FI 20055496A0
Authority
FI
Finland
Prior art keywords
modulators
bind
alpha
domain
collagen receptors
Prior art date
Application number
FI20055496A
Other languages
English (en)
Swedish (sv)
Inventor
Jyrki Heino
Mark Johnson
Jarmo Kaepylae
Anne Marjamaeki
Tommi Nyroenen
Marika Ojala
Olli Pentikaeinen
Liisa Nissinen
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Priority to FI20055496A priority Critical patent/FI20055496A0/fi
Publication of FI20055496A0 publication Critical patent/FI20055496A0/fi
Priority to JP2008530558A priority patent/JP2009509939A/ja
Priority to EP06794113A priority patent/EP1931706A4/en
Priority to CA002622616A priority patent/CA2622616A1/en
Priority to AU2006290621A priority patent/AU2006290621A1/en
Priority to US12/066,955 priority patent/US20090286713A9/en
Priority to RU2008114829/04A priority patent/RU2008114829A/ru
Priority to PCT/FI2006/050396 priority patent/WO2007031608A1/en
Priority to CNA2006800409074A priority patent/CN101300271A/zh
Priority to KR1020087009167A priority patent/KR20080067621A/ko
Priority to IL190130A priority patent/IL190130A0/en
Priority to NO20081336A priority patent/NO20081336L/no
Priority to ZA200802510A priority patent/ZA200802510B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G01N2333/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
FI20055496A 2005-09-16 2005-09-16 Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit FI20055496A0 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20055496A FI20055496A0 (fi) 2005-09-16 2005-09-16 Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit
KR1020087009167A KR20080067621A (ko) 2005-09-16 2006-09-15 콜라겐 수용체 ｉ-도메인 결합 조절제
AU2006290621A AU2006290621A1 (en) 2005-09-16 2006-09-15 Collagen receptor I-domain binding modulators
EP06794113A EP1931706A4 (en) 2005-09-16 2006-09-15 MODULATORS BINDING TO A DOMAIN l OF COLLAGEN RECEPTORS
CA002622616A CA2622616A1 (en) 2005-09-16 2006-09-15 Collagen receptor i-domain binding modulators
JP2008530558A JP2009509939A (ja) 2005-09-16 2006-09-15 コラーゲン受容体のｉドメイン結合モジュレータ
US12/066,955 US20090286713A9 (en) 2005-09-16 2006-09-15 Collagen Receptor I-Domain Binding Modulators
RU2008114829/04A RU2008114829A (ru) 2005-09-16 2006-09-15 Модуляторы связывающих свойств i-домена рецепторов коллагена
PCT/FI2006/050396 WO2007031608A1 (en) 2005-09-16 2006-09-15 Collagen receptor i-domain binding modulators
CNA2006800409074A CN101300271A (zh) 2005-09-16 2006-09-15 结合胶原受体i结构域的调节子
IL190130A IL190130A0 (en) 2005-09-16 2008-03-12 Collagen receptor i-domain binding modulators
NO20081336A NO20081336L (no) 2005-09-16 2008-03-13 Collagen receptor I-domain binding modulators
ZA200802510A ZA200802510B (en) 2005-09-16 2008-03-14 Collagen receptor i-domain binding modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20055496A FI20055496A0 (fi) 2005-09-16 2005-09-16 Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit

Publications (1)

Publication Number Publication Date
FI20055496A0 true FI20055496A0 (fi) 2005-09-16

Family

ID=35151463

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20055496A FI20055496A0 (fi) 2005-09-16 2005-09-16 Kollageenireseptorien alfa-l-domeeniin sitoutuvat modulaattorit

Country Status (13)

Country Link
US (1) US20090286713A9 (fi)
EP (1) EP1931706A4 (fi)
JP (1) JP2009509939A (fi)
KR (1) KR20080067621A (fi)
CN (1) CN101300271A (fi)
AU (1) AU2006290621A1 (fi)
CA (1) CA2622616A1 (fi)
FI (1) FI20055496A0 (fi)
IL (1) IL190130A0 (fi)
NO (1) NO20081336L (fi)
RU (1) RU2008114829A (fi)
WO (1) WO2007031608A1 (fi)
ZA (1) ZA200802510B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009018623A1 (en) * 2007-08-09 2009-02-12 University Of Tasmania Through The Menzies Research Institute Molecular markers and methods related thereto
KR101298651B1 (ko) * 2011-03-16 2013-08-21 연세대학교 산학협력단 효능이 강화된 혈관신생 억제용 약제학적 조성물
CN105418602B (zh) * 2014-08-11 2017-01-11 山东国际生物科技园发展有限公司 一种海洋肽类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501699A (en) * 1982-11-01 1985-02-26 Litton Bionetics, Inc. Maggiemycin, anhydromaggiemycin and processes for making
JP4039856B2 (ja) * 2000-02-03 2008-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 インテグリン発現阻害剤
WO2001073444A2 (en) * 2000-03-28 2001-10-04 Cambridge University Technical Services Limited Receptor/peptide crystal structure for identification of inhibitors
WO2005090297A1 (en) * 2004-03-19 2005-09-29 Biotie Therapies Corporation Sulphonamide derivatives

Also Published As

Publication number Publication date
AU2006290621A1 (en) 2007-03-22
WO2007031608A1 (en) 2007-03-22
NO20081336L (no) 2008-06-06
RU2008114829A (ru) 2009-10-27
US20090286713A9 (en) 2009-11-19
ZA200802510B (en) 2009-01-28
CN101300271A (zh) 2008-11-05
JP2009509939A (ja) 2009-03-12
CA2622616A1 (en) 2007-03-22
EP1931706A4 (en) 2009-05-27
EP1931706A1 (en) 2008-06-18
KR20080067621A (ko) 2008-07-21
IL190130A0 (en) 2008-08-07
US20080255028A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
DK2069335T3 (da) Pyridin-3-ylderivater som immunomoduleringsmidler
DK2069336T3 (da) Pyridin-4-yl-derivater som immunomodulerende midler
BRPI0813653A2 (pt) Compostos de imidazotiazol moduladores de sirtuína
BRPI0813651A2 (pt) Compostos de tiazolopiridina moduladores de sirtuína
BRPI0716325A2 (pt) Composição antimicrobianas
DK2132188T3 (da) Substituerede phenoxy-N-alkylerede thiazolidindioner som østrogenrelaterede receptor-alfa-modulatorer
DE602006011777D1 (de) Acrylhaftklebstoffzusammensetzung für polarisationsfolie
DK1868967T3 (da) Kulbrintesyntese
FR2899479B1 (fr) Composition cicatrisante
DE602007003343D1 (de) Neue mikrobiozide
DE602007002929D1 (de) Lichtempfindliche Zusammensetzung
DE602007008222D1 (de) Diazepanderivate als modulatoren von chemokinrezeptoren
DE502007000290D1 (de) Neue Verwendungen von Nonenolid
DK1967534T3 (da) Klæbende sammensætning
BRPI0813230A2 (pt) Moduladores de calicreína 7
DE602006000877D1 (de) Emulsionszusammensetzung
DK2373652T3 (da) Substituerede piperidin-spiro-pyrrolidinon- og piperidinon-forbindelser anvendt som h3-modulatorer
DE602006011753D1 (de) Sigma-delta-modulatoren
FR2896414B1 (fr) Composition cosmetique matifiante
DE602006011294D1 (de) Klebstoffzusammensetzung
FI20085927A0 (fi) Strukturoitu sideainekoostumus
BRPI0812465A2 (pt) Expressão de fragmento de anticorpo solúvel por truncação de domínio ch1
FR2914651B1 (fr) Composition pour adhesif structural
DK1853601T3 (da) Non-steroide glucocorticoid-receptormodulatorer
DK1888099T3 (da) Hydrerbare keratinsammensætninger

Legal Events

Date Code Title Description
FD Application lapsed